Contact Information: info@facts-care.org
Register

 

 

Annual Multi-Disiplinary Team Building CVT Critical Care Conference

11th Annual Cardiovascular-Thoracic (CVT) Critical Care 2014

Latest Concepts, Protocols, & Technology to Increase Speed of Recovery, Safety & Patient Comfort

Presented in 3 days:

Thursday Oct. 9 thru Saturday Oct. 11, 2014

Omni Shoreham Hotel Washington, DC

This 11th annual multi-disciplinary CME conference is dedicated to further advancing knowledge and expertise in the complex field of Cardiovascular-Thoracic (CVT) Critical Care. It is designed to bring together the entire team of health care professionals that provide care for patients undergoing CVT operations and procedures, including now endovascular procedures.

 

Download Brochure click here

 

 

   

Omni Shoreham Hotel:

Omni Shoreham Hotel

(202) 234-0700

2500 Calvert Street NW

Washington, DC 20008

 

Register

 

  Co-provider and Joint Sponsor:
  aats
  Endorsed by:
  aats


Facts Care Facebook Page


Important Information

Description »


This 11th annual multi-disciplinary CME conference is dedicated to further advancing knowledge and expertise in the complex field of Cardiovascular-Thoracic (CVT) Critical Care. It is designed to bring together the entire team of health care professionals that provide care for patients undergoing CVT operations and interventional procedures.

The conference is directed to:

  • Surgeons, Cardiologists, Interventionalists
  • Intensivists & Anesthesiologists
  • Hospitalists
  • Critical Care Nurses
  • Nurse Practitioners
  • Physician Assistants
  • Perfusionists
  • Cath Lab Professionals
  • Pharmacists
  • Respiratory Therapists
  • Nutritionists

 
The conference addresses the unique physiology, operations, procedures, and potential complications of CVT patients. Latest management strategies for challenging clinical problems will be presented and current controversies discussed. Experts and world authorities will focus on the latest concepts, technology, management protocols, and clinical experience in their specialties.

The program includes faculty presentations, abstract-based scientific sessions, symposia regarding major issues, audience-panel discussions and workshops. Approaches and specific protocols will be related to clinical data, so that participants can structure their clinical practice on evidence-based medicine.

With the field of CVT critical care continuing to change rapidly, it is anticipated that participation in the conference will lead to implementation of new concepts, protocols, and technology. The overall goal is to make the recovery of patients from CVT surgery and interventional procedures faster, safer, and more comfortable.

Fee Structure »


Take advantage of Early Bird pricing and register by September 17, 2014. FACTS-Care Members receive a 15% discount of all prices below. Become a Member today!

Members of these organizations also receive a 15% discount on both the early and full conference registration fees: AATS, STS, SCA (Soc of CV Anes).


Physicians

Allied Health Professionals

Fellows / Students

Full Conference (Early Bird- register by 9/17)

$655

$455

$345

Full Conference (After 9/17)

$755

$555

$445

Thursday and Friday only

$700

$500

$350

Thursday and Saturday only

$650

$450

$350

Friday and Saturday only

$650

$450

$350

Thursday only

$550

$375

$300

Friday only

$550

$375

$300

Saturday only

$400

$300

$225

Note: All registration cancellations are subject to cancellation fee

Contact Us »


For additional information please contact:

Nevin Katz, MD

President & Executive Director, FACTS-Care

Email: info@facts-care.org

 

Mowahib Vermillion

Administrative Assistant, FACTS-Care

Email: mvermillion@facts-care.org or

info@facts-care.org

FACTS-Care

1912 Foxhall Road

McLean, VA 22101

703-992-9948

Practice Gaps and Needs Assessment »


Practice Gaps and Needs Analysis

Practice Gaps

In the last few years, there have been important new developments in the specialty of CVT critical care which have the potential to enhance the quality and safety of CVT critical care. Practice gaps are identified in recent articles such as the one focused on The Society of Thoracic Surgeons 2008 Cardiac Surgery Risk Models. Overall the actual cardiac surgical outcomes are clearly below ideal performance, with the recent analyses documenting importance incidences of : mortality, stroke, reoperation, renal failure, deep sternal wound infection, prolonged ventilation, composite major morbidity, and prolonged length of stay.

At the 2011 Annual Meeting of The Society of Thoracic Surgeons, Shannon and colleagues from the University of Michigan presented important new data in regard to reducing complications and mortality in cardiac surgical patients. Their presentation was entitled "A Novel Method to Evaluate Mortality in Cardiac Surgery: Phase of Care Mortality Analysis, POCMA - A Statewide Quality Collaborative Initiative." They reported that 41% of the mortality during the ICU phase of care is "potentially avoidable." This study, which was subsequently published in the Annals of Thoracic Surgery, emphasizes that important practice gaps still exist.

This conference addresses the major need to highlight the new knowledge in CVT Critical Care so that the developments can be integrated into the practices of the specialty to narrow the practice gaps.

References:
Shahian DM and Edwards FH. The Society of Thoracic Surgeons 2008 Cardiac Surgery Risk Models: Introduction. Ann Thor Surg 2009;88:S1 and related articles Ann Thorac Surg 2009;88:S2-62.

Shannon FL, Fazzalari FL, Theurer PF, Bell, GF, Sutcliffe KM, Prager RL. A method to evaluate cardiac surgery mortality: Phase of care mortality analysis. Ann Thorac Surg 2012;93:36-43.

Nast PA, Avidan M, Harris CB, Krauss MJ, Jacobsohn E, Petlin A, Dunagan WC, Fraser VJ. Reporting and classification of patient safety events in a cardiothoracic intensive care unit and cardiothoracic postoperative care unit. J Thorac Cardiovasc Surg2005;130:1137-43.

Toumpoulis IK, Anagnostopoulos CE, Swistel DG, DeRose J. Does EuroSCORE predict length of stay and specific postoperative complications after cardiac surgery? Eur J Cardiothoracic Surg 2005;27:128-133.

 

Needs Assessment

Cardiovascular-thoracic (CVT) critical care is now recognized as a unique specialty within the frameworks of CVT surgery, interventional cardiology, interventional radiology and general critical care. The overall field of CVT critical care now includes care of patients undergoing not only classical cardiac surgical operations, but also endovascular and minimally invasive surgery, interventional cardiology procedures, and interventional radiological procedures.

Although the CVT surgeon has traditionally provided perioperative care with the assistance of residents and fellows, the organization of the CVT critical care team is changing. CVT critical care is increasingly being provided by a multi-disciplinary team. The team includes: CVT surgeons, intensivists and anesthesiologists, hospitalists, critical care nurses and nurse practitioners, physician assistants, perfusionists, cath lab professionals, respiratory therapists, pharmacists, and nutritionists. It is essential that these multi-disciplinary professionals share a broad understanding of the care, so that they can function well as a team to enhance speed of recovery, quality, safety, and patient comfort.

The increasing complexity of CVT critical care requires a new level of critical care performance. This new critical care specialty is faced with major challenges:
 

  • A rapid evolution in critical care concepts, pharmacology and technology.
  • The unique physiologic states and complications experienced by CVT patients.
  • The aging CVT patient population with more advanced primary disease and associated conditions.
  • Major advances in surgical techniques, interventional procedures and the accompanying technology.
  • National regulations limiting house staff work hours that accentuate the shortage of critical care staff.
  • The difficulty in providing comfortable care with patients subjected to multiple negative sensory inputs including monitoring sounds, alarms, technical language, and procedures.
  • The increasing number of disciplines included on the CVT critical care team.
  • The well-documented compromises in medical practice safety.

 

This 11th annual multi-disciplinary conference, “Cardiovascular-Thoracic (CVT) Critical Care 2014,” addresses these challenges as follows:

  • The conference is dedicated to presenting the latest information and innovative concepts and technology in CVT Critical Care.
  • Basic approaches and specific protocols will be related to clinical data so that participants can structure their clinical practice on “evidence based medicine.”
  • The program agenda has been designed with the assistance of multi-disciplinary specialists.
  • Experts and world authorities will present the latest concepts, protocols and clinical experience in their specialties.
  • The importance of the multi-disciplinary approach to CVT critical care will be emphasized.
  • To help critical care personnel understand the patient’s perspective, a discussion led by the patient organization Mended Hearts will be presented.

 

In the last few years, there have been important new developments in the specialty which have the potential to enhance the quality and safety of CVT critical care. This conference addresses the major need to highlight new developments, so that the latest knowledge can be integrated into practice:

  • New hemodynamic monitoring and point of care technologies have been developed. How to employ these new methods to guide management will be discussed.
  • There is an evolution in cardiovascular therapeutic agents and interventions to address the challenges of low cardiac output, right heart failure, and pulmonary hypertension. New pharmacologic and interventional approaches for impaired hemodynamics will be presented and further discussed in the audience panel discussions.
  • Bedside ultrasound technology now makes possible early bedside diagnosis of mechanical hemodynamic problems and increases the safety of deep line placement. The bedside ultrasound workshop will facilitate integration of these techniques into clinical practice.
  • The technology to provide circulatory support continues to evolve rapidly and includes a variety of percutaneous devices. The postoperative management of patients on such devices is complex and will be addressed through a presentation and a workshop.
  • Extra-corporeal membrane oxygenation (ECMO) has increasingly been employed for the treatment of acute respiratory failure. New information regarding the application of ECMO will be the subject of a presentation and will be addressed in a workshop.
  • Adequate, safe pain control and sedation in CVT patients and the prevention and treatment of delirium are continuing challenges in the CVT ICU. Latest data and management protocols will be presented.
  • Management of patients who are bleeding after cardiac surgery continues to challenge the CVT ICU team and will be discussed.
  • Volume overload and acute renal failure continue to be major challenges in CVT patients. Protocols and controversies regarding renal replacement therapy will be presented.
  • Infection continues to be an important complication in CVT patients. The latest concepts and guidelines to prevent and manage sepsis will be discussed.

 

Educational Objectives »

The overall educational objectives of “Cardiovascular-Thoracic (CVT) Critical Care 2014” are:

  • Apply the latest concepts, technology and developments in CVT critical care to optimize patient outcomes.
  • Understand the latest innovations and protocols in cardiac, respiratory and renal support. 
  • Recognize the importance of the multi-disciplinary team approach in CVT critical care and principles of the team coordination.

  Educational objectives of “Cardiovascular-Thoracic (CVT) Critical Care 2014” include:

  • Evaluate the latest choices in hemodynamic monitoring and point of care technology.
  • Apply the pharmacologic and mechanical support approaches to severe postoperative heart failure.
  • Examine how interventional cardiology procedures are employed before and after cardiac surgery.
  • Integrate into practice the latest concepts and protocols for diuretics and renal replacement therapy.
  • Evaluate how current ventricular assist devices are employed in CVT critical care and how to deal with emergencies.
  • Examine a stepwise approach to bleeding after cardiac surgery.
  • Understand how optimal sedation and analgesia are achieved for complex CVT critical care patients.
  • Evaluate how ECMO technology and protocols are employed in CVT critical care.
  • Understand how the latest bedside echocardiography - ultrasound technology is used to diagnosis hemodynamic mechanical problems and to guide placement of deep catheters.
  • Examine how the latest hemodynamic monitoring technology is used to guide management of low cardiac output.
  • Obtain a perspective of how CVT ICU protocols are developed and implemented and how the results are analyzed.
  • Apply the latest diagnostic and management protocols to the occurrence of pulmonary embolism in CVT patients.
  • Evaluate the latest concepts and protocols for prevention, diagnosis and management of acute stroke after cardiac surgery.
  • Assess the latest pharmacologic and surgical approaches to atrial fibrillation.
  • Apply the latest protocols in anticoagulation after cardiac valve replacement surgery.
  • Evaluate the latest methods of nutritional support for CVT ICU patients.
  • Gain an understanding of the latest innovations in cardiac surgery.
  • Assess the latest advances in minimally invasive thoracic surgery and the associated postoperative care.
  • Understand the selection of open versus percutaneous tracheostomy and the timing of the procedure.
  • Apply the latest preventive and management protocols to GI bleeding in CVT patients.
  • Evaluate the perioperative management of acute and chronic hepatic failure in CVT patients.
  • Assess the ethical issues associated with advanced critical care technology.
  • Integrate into practice the latest principles and protocols for the management of pneumonia in CVT ICU patients.
  • Understand the patient’s and family’s perspective regarding CVT critical care.

 

CE Accreditation »


This activity will be planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME).

Nurses

This activity is pending approval with The Association of periOperative Registered Nurses.

 

Perfusionist Accreditation

This activity is pending approval with the American Board of Cardiovascular Perfusion (ABCP).

Disclosure policy:

 

IFor further information on the Accreditation Council for Continuing Medical Education (ACCME) Standards of Commercial Support, please visit www.accme.org.

Group Rate Hotel Information »


Omni Shoreham Hotel Washington, DC
The Omni Shoreham Hotel welcomes attendees of Cardiovascular-Thoracic Critical Care 2014. To reserve your room now and receive the special conference rate simply click on the "book now" button below.

Conference Dates: Oct 9, 2014 - Oct 11, 2014
Additional Dates: Oct 8, 2013 - Oct 14, 2014
Special Rate: $259 per night Book Now »
Hotel Group Discount Deadline Sept 17, 2014


Omni Shoreham Hotel

(202) 234-0700

2500 Calvert St NW, Washington, DC 20008

Group Code 12400611731


Agenda, Faculty & Abstract/Poster Submission

Agenda »

Thursday, October 9, 2014

7:00am - 8:00 am
Light Breakfast & Registration

Session I  –  Introduction & Cardiovascular

8:00 am  - 8:10 am
Welcome &  Introduction to the Program
Nevin M. Katz, MD

8:10 am  – 8:40 am
Transcatheter Aortic Valve Replacement (TAVR) - Procedures, Results, & ICU Management
Vinod  H. Thourani, MD

8:40 am  – 9:10 am
Management of  VAD & ECMO Complications
William R. Lynch, MD,  & David C. Fitzgerald, CCP

9:10 am  – 9:30 am
CV  - Case Scenarios
Hirose Hitoshi, MD, William R. Lynch, MD, & David C. Fitzgerald, CCP

9:30 am  – 10:00 am
Audience Panel Discussion
Moderator: Nevin M. Katz, MD
Panelists: Michael Doll, PA-C, Myra F. Ellis, CCRN,David C. Fitzgerald, CCP,
 Hirose Hitoshi, MD, Marsha Holton, CCRN & William R. Lynch, MD

10:00 am  - 10:30 am
Refreshment Break - Exhibit Hall

Session II  -  Cardiothoracic Resident /  Fellow Research  Award & Presentation

10:30 am – 11:00 am
“CT Resident / Fellow Research Award" Presentation
TBA
Award presented by: TBA

Session III  -  Innovative  Approaches to CVT Critical Care - International Abstract-Based Scientific Session

11:00 am  - 11:50 am
Moderator: Daniel L. Miller, MD

Abstract-Based Presentation 1
TBA
Discussant: TBA

Abstract-Based Presentation 2
TBA
Discussant: TBA

11:50 am  – 12:00 pm
Intermission - Exhibit Hall

Session IV - Professional Multi-Disciplinary Issues - Networking Luncheon Symposium  

12:00 pm  – 1:00 pm
CVT Critical Care Handoffs: "The Good, the Bad, and the Ugly"
Moderator: Mary J. Zellinger, CCRN
Panelists: Charles M. Geller, MD, Robert E. Moyneaux, PA-C, Denese Sabatino, CCRN

1:15 pm  – 2:15  pm
Non-CME Focus Groups & Exhibit Hall Demonstrations - Latest Technology & Pharmaceuticals

TBA
Discussion Leader: TBA
Location: Hampton Room

TBA
Discussion Leader: TBA
Location:  Calvert Room

TBA
Discussion Leader: TBA
Location:  Governor's  Room

Session V  –  Thoracic Surgery & Cardio-Respiratory Support

2:30 pm  - 3:00 pm
Advanced Resp Support &  ECMO – Case Scenarios with Latest Strategies
Eric Kriner, RRT, Hirose Hitoshi, MD, & David C. Fitzgerald, CCP

3:00 pm  – 3:30 pm
Thoracic Surgical Critical Care & Bronchoscopy
Daniel L. Miller, MD

3:30 pm  – 4:00 pm
Critical Care Issues in Thoracic Surgical ICU
Namrata Patil, MD

4:00 pm  – 4:30 pm
Refreshment Break - Exhibit Hall

Session VI  -  Multi-Disciplinary Break Out Workshops

4:30 pm  – 6:00 pm

Bronchoscopy Simulation
Director: James P. Lamberti, MD & Co-Director: Namrata Patil, MD
Location: Congressional  Room

Cardiac Advanced Life Support (CALS) Protocols
Director: Rakesh C. Arora, MD, PhD; Co-Director: S.  Jill Ley, RN, CNS
Location: Hampton Room

Hemodynamic Simulation – Case Scenarios including Patient with VAD
Director: Nevin M. Katz, MD
Location: Blue Room

Friday, October 10, 2014

7:00 am – 8:00 am
Light Breakfast & Registration

Session VII  – Innovations in Anticoagulation, Coagulopathy Management & Blood Conservation

Moderator: Jerrold H. Levy, MD

8:00 am  – 8:30 am
Anticoagulation for VAD's & ECMO
Michael Moranville, PharmD

8:30 am  - 9:00 am
Management of Coagulopathies
Jerrold H. Levy, MD

Session VIII - Ethical Issues

Moderator: Moderator: Namrata Patil, MD

9:00 am  - 9:30 am
The Ethics of Advanced Critical Care Technology & Case Scenario
Melissa M. Goldstein, JD & Myra F. Ellis, CCRN

Session IX  -  Andrew Foster Young Investigator Award & Presentation

9:30 am – 10:00 am
Andrew Foster “Young Investigator” Presentation & Discussion
TBA
Award presented by Joseph M. Giordano, MD

10:00 am - 10:30 am
Refreshment Break - Exhibit Hall

Session X  –  The Patient’s Perspective

10:30 am  – 11:00 am
The Patient’s Perspective Panel
Mended Hearts Moderator & Representatives & Barbara Jacobs, CCRN

Session XI  –  Innovative  Approaches to CVT Critical Care - International Abstract-Based Scientific Session

11:00 am  - 11:45 pm
Moderator: Charles Geller, MD
TBA

Abstract-Based Presentation 4
TBA
Discussant: TBA

Abstract-Based Presentation 5
TBA
Discussant: TBA

11:45 am  – 12:00 pm
Intermission - Exhibit Hall

Session XII - Luncheon Symposium

12:00 pm – 1:00 pm
KEYNOTE ADDRESS: Meeting the Challenges to Improve Quality & Safety – The TeamSTEPPS Program
Charles E. Murphy, MD

1:15pm  – 2:15  pm
Non-CME Focus Groups & Exhibit Hall Demonstrations - Latest Technology & Pharmaceuticals

TBA
Discussion Leader: TBA
Location: Hampton Room

TBA
Discussion Leader: TBA
Location:  Calvert Room

TBA
Discussion Leader: TBA
Location:  Governor's  Room

Session XIII  -  Endocrine Issues & Physical Therapy

Moderator: TBA

2:30 pm  – 3:00 pm
Glycemic Control & Diabetic Issues - Addressing the New SCIP Measures
Marc S. Sussman, MD

3:00 pm  - 3:30 pm
Physical Therapy & Early Mobilization for the CVT Critical Care Patient
Emily C. Shields, PT

3:30 pm  – 4:00 pm
Refreshment Break - Exhibit Hall

Session XIV -  Multi-Disciplinary Break Out Workshops

4:00 pm  – 5:30 pm

Bedside Echocardiography & Ultrasound Guided Procedures
Director: Haney Mallemat, MD & Co-Director: Glenn Whitman, MD
Location: Congressional Room

ECMO / Temporary Circulatory Support - Protocols & Bedside Issues
Co-Directors:  David C. Fitzgerald, CCP, Hirose Hitoshi, MD, & William R. Lynch, MD
Location: Blue Room

TeamSTEPPS Protocols
Director: Charles E. Murphy, MD & Co-Director: Margaret H. Sturdivant, RN
Location: Hampton Room


Session XV - Abstract-Based Poster Session

5:30 pm  – 7:00 pm
Poster Session with Professor Rounds – Wine & Cheese Event  -  Exhibit Hall & Patio           

Saturday, October 11, 2014

7:00 am  - 8:00 am
Light Breakfast and Registration

Session XVI  -  Neurologic  & Sepsis Issues

Moderator: Joseph F. Dasta, MSc

8:00 am  – 8:30 am
Seizure Management - The New Guidelines
Gretchen M. Brophy, PharmD

8:30 am  – 9:00 am
Antibiotics for Open Chest, ECMO, and VAD Patients
Jessica R. Crow, PharmD

Session XVII  –  The CT Resident Scholarship Panel Discussion

9:00 am  – 9:30 am
CT Resident Perspective - Providing Optimal CVT Critical Care
Moderator: TBA
Panel: Recipients of  CT Resident Scholarships

9:30 am - 9:45 am
Refreshment Break - Exhibit Hall

Session XVIII  – Renal & Nutritional Support  

9:45 am  – 10:15 am
The New Renal Biomarkers for  Acute Kidney Injury - Latest Developments in Early Diagnosis & Treatment
John A. Kellum, MD

10:15 am  – 10:45 am
Latest Concepts & Practice for  CVT Critical Care Nutritional Support
Patricia Brown, RD, LDN, CNSC

Session XIX - Best Practices & Challenges

10:45 am - 11:15 am
Drug Shortages -  How to Address the Ongoing Challenge
John J. Lewin III, PharmD

11:15 am
Closing Comments
Nevin M. Katz, MD

Please Note: Program Agenda is subject to change.

 

Faculty »



Conference Director

Nevin M. Katz, MD
President & Executive Director, FACTS-Care
Associate Professor of Surgery
Johns Hopkins University
The Johns Hopkins Hospital
Baltimore, MD

 

Conference Co-Directors

Joseph F. Dasta, MSc
Professor Emeritus
The Ohio State University College of Pharmacy
Columbus, OH
Adjunct Professor
University of Texas College of Pharmacy
Round Rock, TX

Jerrold H. Levy, MD, FAHA, FCCM
Professor of Anesthesiology
Co-Director, Cardiothoracic ICU
Duke University Medical Center
Durham, North Carolina

Daniel L. Miller, MD
Chief, General Thoracic Surgery
Professor of Thoracic Surgery
Emory University
Atlanta, GA

Mary J. Zellinger, RN, MN, ANP-BC, CCRN-CSC
Clinical Nurse Specialist
Cardiovascular and Critical Care Services
Emory University Hospital
Atlanta, GA

 

 

Invited Faculty

 

Rakesh C. Arora, MD, PhD
Assistant Professor of Surgery / Physiology
University of Manitoba
Winnepeg, MB
Canada

Gretchen M. Brophy, PharmD
Neurocritical Care Clinical Pharmacist
Professor of Pharmacotherapy &
Outcomes Sciences & Neurosurgery
Virginia Commonwealth University
Richmond, VA

Patricia Brown, RD, LDN, CNSC
Senior Clinical Dietician
Parenteral Enteral Support Service
Department of Surgery
The Johns Hopkins Hospital
Baltimore, MD

Jessica R. Crow, PharmD
Clinical Specialist
Cardiac Surgical Intensive Care &
Nutrition Support Service
Department of Pharmacy
The Johns Hopkins Hospital Baltimore, MD

Michael C. Doll, MPAS, PA-C
Chief Physician Assistant
Division of Cardiac Surgery
Geisinger Medical Center
Danville, PA

Myra F. Ellis, RN, MSN, CCRN-CSC
Clinical Nurse IV – CT ICU
Duke University Hospital
Durham, NC

David C. Fitzgerald, CCP
Chief of Cardiovascular Perfusion
ECMO Coordinator
INOVA Fairfax Hospital
Falls Church, VA

Joseph M. Giordano, MD
Professor Emeritus
Department of Surgery
The George Washington University
Washington, DC

Charles M. Geller, MD
Director Cardiac Surgery ICU
Attending, Cardiac Surgery
Division of Cardiothoracic Surgery
Mount Sinai Beth Israel
New York, NY

Melissa M. Goldstein, JD
Associate Professor
Department of Health Policy
School of Public Health & Health Sciences
The George Washington University
Washington, DC

Hitoshi Hirose, MD
Associate Professor of Surgery
Division of Cardiothoracic Surgery
Thomas Jefferson University
Philadelphia, PA

Marsha Holton, CCRN, RCIS, FSICP
President
Cardiovascular Orientation Programs
Clinical Coordinator
Indian Head, MD

Barbara S. Jacobs, RN, MSN, CCRN, CENP
Senior Director, Nursing Operations
Suburban Hospital
Johns Hopkins Medicine
Bethesda, MD  

John A. Kellum, MD
Professor
Department of Critical Care Medicine
Director, Center for Critical Care Nephrology
University of Pittsburgh
Pittsburgh, PA

Eric Kriner, BS, RRT
Pulmonary Critical Care Clinical Specialist
Medstar Washington Hospital Center
Pulmonary Services Department
Washington, DC

James P. Lamberti, MD
Medical Director
Respiratory Care Services
INOVA Fairfax Hospital
Falls Church, VA

John J. Lewin, III, PharmD, MBA
Division Director, Critical Care & Surgery Pharmacy
The Johns Hopkins Hospital
Adjunct Assistant Professor,
Anesthesiology & Critical Care Medicine
Johns Hopkins University
Clinical Professor,
University of Maryland School of Pharmacy
Baltimore, MD

S. Jill Ley, RN, MS, CNS
Clinical Nurse Specialist
Adult & Pediatric Cardiac Surgery
California Pacific Medical Center
San Francisco, CA

William R. Lynch, MD
Associate Professor of Surgery
Section of Thoracic Surgery
University of Michigan
Ann Arbor, MI

Haney Mallemat, MD
Assistant Professor
Department of Critical Care Medicine
Department of Emergency Medicine
University of Maryland Medical Center
Baltimore, MD

Robert E. Molyneaux, PA-C
Chief Physician Assistant
Surgical Critical Care Services
Medstar Washington Hospital Center
Washington, DC

Charles E. Murphy, MD
Assistant Professor of Surgery
Division of Cardiovascular & Thoracic Surgery
Director, Cardiothoracic ICU & Stepdown Units
Duke University
Durham, NC

Michael Moranville, PharmD
Pharmacy Clinical Specialist
Advanced Heart Failure & Thoracic Transplantation
Johns Hopkins Hospital
Baltimore, MD

Namrata Patil, MD, MPH
Director, Thoracic Intermediate Care Unit
Associate Surgeon
Brigham & Women’s Hospital
Instructor in Surgery
Harvard Medical School
Boston, MA
Denese Sabatino, MSN, ARNP, NP-C, CCRN
Clinical Nurse Specialist
Department of Critical Care
Cleveland Clinic Florida
Weston, FL

Emily C. Shields, PT, DPT, CCS
ICU Senior Physical Therapist
Medstar Washington Hospital Center
Washington, DC

Margaret H. Sturdivant, MSN, RN
Administrative Director
Duke University Health System
Patient Safety Office
Durham, NC

Marc S. Sussman, MD
Assistant Professor of Surgery
Division of Cardiovascular Surgery
Johns Hopkins University
Baltimore, MD

Vinod H. Thourani, MD
Associate Professor of Surgery
Division of Cardiothoracic Surgery
Emory University
Atlanta, GA

Glenn Whitman, MD
Director, Cardiac SICU
The Johns Hopkins Hospital
Associate Professor of Surgery
Johns Hopkins University
Baltimore, MD

Abstract Submission Guidelines »

Abstract Submission Guidelines

Abstract-Based Scientific & Poster Sessions, and Andrew Foster Young Investigator Award, CT Resident & Fellow Investigator Award.


Abstract Submission Deadline July 1, 2014


In addition to the Andrew Foster Young Investigator Award, FACTS-Care is instituting a new Abstract-Based Cardiac-Thoracic Resident & Fellow Research Award for the CVT Critical Care 2014 Conference. We hope these two awards will encourage Young Investigators and CT Residents & Fellows to pursue research projects. For the winner of each award:

  • A $1,000 award for the best selected abstract for each award
  • A 10 minute presentation at a plenary session based on the research during the CVT Critical Care 2014 conference
  • Winning abstracts included in the course syllabus
  • Option to additionally present at the Poster Session with Professor Rounds – Wine & Cheese Event 

It has been clear from the beginning of our “CVT Critical Care” conferences, that many of our participants are dynamic leaders in their hospitals, and are involved with developing and studying innovations in CVT critical care.  These new sessions provide an opportunity for multi-disciplinary professionals to highlight their studies in the following categories:

  • Management of CVT Critical Care Issues
  • Evaluation of New Technology and Pharmaceuticals
  • Organization of the CVT Critical Care Multi-Disciplinary Team

The “Abstract Judging” subcommittee of our 2014 Program Committee will judge all Abstracts using a blinded format.
All abstract presentations will be 10 minutes, with a 5-minute Audience-Panel discussion to follow. Overall then, 6 presentations will be selected, and the authors honored at the presentation sessions.

 

Abstract Submission Instructions:


Andrew Foster Young Investigator Award
Abstracts submitted for the “Andrew Foster Young Investigator Award” must be from investigators 35 years of age or younger, whose abstract describes research related to CVT Critical Care. The presentation will be on Friday Oct 10, at 9:30 am.

CT Resident & Fellow Investigator Award
Abstracts submitted for the “CT Resident & Fellow Investigator Award” must be from CT Residents or Fellows in Cardiothoracic Surgery programs. The presentation will be on Thurs Oct 9, at 10:30 am.

Abstract-Based Scientific Session

All disciplines are encouraged to submit abstracts for the “Abstract-Based Scientific Sessions.”

The “Abstract-Based Scientific Sessions” will be held on the 1st and 2nd days of the conference, Thurs Oct 9 and Fri Oct 10, from 11:00 am - 11:45 am.

Poster Session

All disciplines are encouraged to submit abstracts for the “Poster Session.”

The Posters will be displayed both days of the conference in the Exhibit Hall, and will be honored at a “Wine & Cheese Event” in the Exhibit Hall, Fri Oct 10, from 5:30 pm – 7:00 pm

A standard 4' x 8' poster display board will be provided

All Abstracts must include the following:
- Name and degrees(s) of all authors, with presenting author’s name in upper case
- Name of the hospital(s) where the study was performed
- Brief title of the abstract, including the nature of the study only
- Do not underline the title
- Abstract submitted for (1 or more) of the following:
Andrew Foster Young Investigator, CT Resident & Fellow Investigator, Abstract-Based Scientific Session and Poster Session.

-The abstract text should include the following:
- A concise statement of the investigation’s purpose
- A brief explanation of the study’s materials and methods
- A summary of the study’s results
- Conclusions supported by the investigation’s results.

Please note:
- Do not include references or graphics
- Abstracts should not exceed 500 words
- The Abstract deadline is July 1, 2014.

Abstracts should be e-mailed to: info@facts-care.org, and adhere to the above guidelines.
Abstract Submission Deadline Extended to July 1, 2014!

Include the following contact information and if you would like to be considered for the Andrew Foster Award (you must meet the criteria as indicated below on this page) for the presenting author on a cover page.

The Program Committee members will review your abstract, and you will be notified of their decision by August 20, 2014.

If your abstract is selected, you will be asked to present it as either (a) a poster only or (b) a 10 minute conference presentation on date TBD, as the winner of the Andrew Foster Award . You will receive complete information (including poster dimensions, set-up times, etc.) after notification of the Program Committee's decision.

If accepted for presentation or display, your abstract will be printed in the course syllabus as submitted, so please edit and proofread carefully.

If you have any questions about the above guidelines, please contact:

Nevin Katz, MD
President & Executive Director, FACTS-Care
Email: info@facts-care.org

or

Mowahib Vermillion

Administrative Assistant, FACTS-Care

Email: info@facts-care.org

 

 

Program Committee »

Program Committee

 

Jessica Crow, PharmD
Baltimore, MD, USA
Faculty member has nothing to disclose with regard to commercial support.

Faculty member does not plan on discussing unlabeled/investigational uses of a commercial product and will disclose this to the audience.

Joseph Dasta
Round Rock, TX, USA
Faculty member is a consultant for Abbvie, Acel-Rx Pharmaceuticals, Covidien-Mallinckrodt, Grifols, Hospira, Jansen, Otsuka American Pharmaceuticals and Pacira Pharmaceuticals. Faculty member is a shareholder of Abbvie, BMS, Lilly, Phizer, Merck and ESI.

Faculty member plans on discussing unlabeled/investigational uses of a commercial product and will disclose this to the audience

Myra Ellis, CCRN
Durham, NC, USA
Faculty member has nothing to disclose with regard to commercial support.

Faculty member does not plan on discussing unlabeled/investigational uses of a commercial product.

Charles Geller, MD
New York, New York, USA
Faculty member has nothing to disclose with regard to commercial support.

Faculty member does not plan on discussing unlabeled/investigational uses of a commercial product.

Hitoshi Hirose, MD
Philadelphia, PA, USA
Faculty member has nothing to disclose with regard to commercial support.

Faculty member does plan on discussing unlabeled/investigational uses of a commercial product.

Nevin M. Katz, MD
McLean, VA, USA
Faculty member is on Steering Committee for Grifols.

Faculty member does not plan on discussing unlabeled/investigational uses of a commercial product.

Jerrold Levy, MD
Durham, North Carolina, USA
Faculty member is a consultant for Octapharma and Portola Marathon Roche. Faculty member is on Steering Committee for CSL Behring, Jausen, Grifols, B-I and The Medicines Company.

Faculty member does plan on discussing unlabeled/investigational uses of a commercial product and will disclose this to the audience. 

William R. Lynch, MD
Ann Arbor, MI, USA
Faculty member has nothing to disclose with regard to commercial support.

Faculty member plans on discussing unlabeled/investigational uses of a commercial product.

Daniel L. Miller
Atlanta, GA, USA
Faculty member has nothing to disclose with regard to commercial support.

Faculty member does not plan on discussing unlabeled/investigational uses of a commercial product.

Robert E. Molyneaux, PA-C
Washington, DC USA
Faculty member has nothing to disclose with regard to commercial support.

Faculty member does not plan on discussing unlabeled/investigational uses of a commercial product.

Namrata Patil, MD
Boston, Massachusetts, USA
Faculty member is a Minor Stockholder for Apple, GE, Intel, and AT & T. Faculty member is a Research Support Recipient from NIH/NIAID
 
Faculty member plans on discussing unlabeled/investigational uses of commercial products and will disclose this to the audience.

Denese Sabatino, CCRN
Miami, Florida USA
Faculty member has nothing to disclose with regard to commercial support.

Faculty member does not plan on discussing unlabeled/investigational uses of a commercial product.

Mary J. Zellinger, CCRN
Atlanta, Georgia, USA
Faculty member has nothing to disclose with regard to commercial support.

Faculty member does not plan on discussing unlabeled/investigational uses of a commercial product.

 


Supporters and Exhibitors

Council for Excellence »

Council for Excellence

 

We are grateful for the support of the following members of FACTS-Care’s Council for Excellence in CVT Critical Care:

 

   
Edwards Lifesciences edwards
Abbott Point of Care abbott

SonoSite, Inc

sonosite
The Medicines Company abbott
The Mended Heart mh
Abiomed abiomed
Hospira hospira
Grifols a
Gambro s
Masimo a
Clearflow clearflow
Astute Medical astute
Covidien covidien
The George Washington University - Universal Health Services  
   
   

 

2014 Exhibitors »

 

 

Gold Exhibitors:

Edwards Lifesciences edwards
Abiomed abiomed
Hospira hospira
Clearflow clearflow
Abbott Point of Care abbott
Covidien x
Astute x
   

 

Silver Exhibitors:

Thoratec x
   
   
   
   

 

Bronze Exhibitors:

rEvo Biolics  
CT Assist  
Elsevier Affilaite / Atlantic Medical Books  
   
   

 

miller
conf
Download 2014 Brochure

Home | Annual Conference | Regional Conference | On-Line CE | About | Contact
Privacy Policy | Membership | Testimonials

© FACTS-Care - All Rights Reserved